- Lobbying
- Jessica AND Woolley
Lobbying Arrangements Results for 'Jessica Woolley'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Matters pertaining to a proposed pilot program to make the federal student loan collection process more transparent and consumer-oriented. |
Van Ru Credit Corporation
|
DLA Piper LLP (US) | |||
Details U.S. international development policy and trade. |
Aeolus Kenya Limited (AKL)
|
DLA Piper LLP (US) | |||
Details Issues related to the Ted Stevens Olympics & Amateur Sports Act. S. 2330, Empowering Olympic & Amateur Athletes Act of 2019. |
National Governing Body Task Force
|
DLA Piper LLP (US) | |||
Details Efforts on safety regulations - padded undergarments. |
Limited Brands
|
DLA Piper LLP (US) | |||
Details Matters relating to the impact of tax reform on real estate investments. |
Ashley Companies
|
DLA Piper LLP (US) | |||
Details Proposals to reauthorize the Farm Bill. Legislative and regulatory matters affecting the client and the beverage industry at large. |
The Coca-Cola Company
|
DLA Piper LLP (US) | |||
Details Federal response to coronavirus pandemic. |
Chipotle Mexican Grill, Inc.
|
DLA Piper LLP (US) | |||
Details Regulatory and legislative issues associated with aluminum warehousing. |
American Beverage Association
|
DLA Piper LLP (US) | |||
Details S. 2248, Foreign Intelligence Surveillance Amendments Act of 2007. |
Verizon Communications
|
DLA Piper LLP (US) | |||
Details Biodiesel tax credit. Renewable Fuel Standard. Oil spill excise tax. Climate legislation and policies. |
INDEPENDENT FUEL TERMINAL OPERATORS ASSOCIATION
|
DLA Piper LLP (US) | |||
Details Legislative and regulatory proposals related to pharmaceutical distribution and veterans health. |
McKesson Corporation
|
DLA Piper LLP (US) | |||
Details Matters relating to foreign direct investment. |
DUBAI GROUP
|
DLA Piper LLP (US) | |||
Details Financial insurance policy and title insurance matters. |
Westcor
|
DLA Piper LLP (US) | |||
Details Trade enforcement issues. |
JS International, Inc.
|
DLA Piper LLP (US) | |||
Details Issues related to the Strategic Petroleum Reserve. H.R. 2028, Energy and Water Development and Related Agencies Appropriations Act, FY2016, provisions on product reserve. |
Colonial Oil Industries, Inc.
Petroleum products. |
DLA Piper LLP (US) | |||
Details Tax reform proposals. |
AARP
|
DLA Piper LLP (US) | |||
Details S. 3880, SMART Copyright Act of 2022. |
INTERNET COMMERCE COALITION
|
DLA Piper LLP (US) | |||
Details U.S. government support for 2028 Olympic Games in Los Angeles. |
LA 2028
|
DLA Piper LLP (US) | |||
Details International tax and trade issues with respect to importation and valuation of distilled spirits. Legislative proposals affecting the alcohol industry. Monitor economic trade legislation and relat... |
DIAGEO NORTH AMERICA
|
DLA Piper LLP (US) | |||
Details H.R. 4365/S. 2587, Department of Defense Appropriations Act, FY2024, provisions regarding funding for artificial intelligence research. H.R. 2670/S. 2226, National Defense Authorization Act for FY2... |
Trine University
|
DLA Piper LLP (US) | |||
Details Legislative and regulatory issues affecting the financial services industry and issues relating to student lending policy. |
Discover Financial Services, Inc.
|
DLA Piper LLP (US) | |||
Details H.R. 4365/S. 2587, Department of Defense Appropriations Act, FY2024, provisions regarding commercial satellites. Air Force procurement issues. Cybersecurity and orbital debris issues. H.R. 4367/S. ... |
ViaSat, Inc.
|
DLA Piper LLP (US) | |||
Details Monitoring issues related to credit ratings, vendor management, and supply chain risk management. Market entry opportunities for new supply chain risk management technology. H.R. 7617, Department o... |
Rapid Ratings International Inc.
|
DLA Piper LLP (US) | |||
Details Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S... |
Novo Nordisk Inc.
|
DLA Piper LLP (US) |